Ca M Kinase II mediates maladaptive post‐infarct remodeling and pro‐inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Ca MKII was suggested to mediate ischemic myocardial injury and adverse cardiac remodeling. Here, we investigated the roles of different Ca MKII isoforms and splice variants in ischemia/reperfusion (I/R) injury by the use of new genetic Ca MKII mouse models. Although Ca MKII δC was upregulated 1 day after I/R injury, cardiac damage 1 day after I/R was neither affected in Ca MKII δ‐deficient mice, Ca MKII δ‐deficient mice in which the splice variants Ca MKII δB and C were re‐expressed, nor in cardiomyocyte‐specific Ca MKII δ/γ double knockout mice ( DKO ). In contrast, 5 weeks after I/R, DKO mice were protected against extensive scar formation and cardiac dysfunction, which was associated with reduced leukocyte infiltration and attenuated expression of members of the chemokine (C‐C motif) ligand family, in particular CCL 3 (macrophage inflammatory protein‐1α, MIP ‐1α). Intriguingly, Ca MKII was sufficient and required to induce CCL 3 expression in isolated cardiomyocytes, indicating a cardiomyocyte autonomous effect. We propose that Ca MKII ‐dependent chemoattractant signaling explains the effects on post‐I/R remodeling. Taken together, we demonstrate that Ca MKII is not critically involved in acute I/R‐induced damage but in the process of post‐infarct remodeling and inflammatory processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300 · cited 2×
“…phase and exhibit phagocytic, proteolytic, and inflammatory functions, while (II) Ly-6C lo monocytes dominate the later phase by expressing vascular endothelial growth factor and promoting healing via myofibroblast accumulation, angiogenesis, and deposition of collagen (Nahrendorf et al , 2007).”
Sensitivity of CaM Kinase II to the Frequency of Ca 2+ Oscillations
De Koninck, P., & Schulman, H. (1998) · Science · doi:10.1126/science.279.5348.227 · Cited by 1,269 · cited 1×
“It is activated by Ca 2+ /calmodulin, direct oxidation and a b -arrestin-dependent mechanism (De Koninck & Schulman, 1998; Erickson et al , 2008; Mangmool et al , 2010; He et al , 2011).”
A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation
Erickson, J. R., Joiner, M.-L. A., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., Bartlett, R. K., Lowe, J. S., O'Donnell, S. E., Aykin-Burns, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.048 · Cited by 1,122
Apoptosis in human acute myocardial infarction.
Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M., & Voipio-Pulkki, L.-M. (1997) · Circulation · doi:10.1161/01.cir.95.2.320 · Cited by 825 · cited 1×
“Because both apoptosis and necrosis mediate cell death in MI and I/R (Saraste et al , 1997; James, 1998; McCully et al , 2004), we also measured high-sensitive cardiac Troponin T (hsTnT) serum levels as a marker for myocardial cell death.”
Structure–function of the multifunctional Ca2+/calmodulin-dependent protein kinase II
HUDMON, A., & SCHULMAN, H. (2002) · Biochemical Journal · doi:10.1042/bj20020228 · Cited by 615 · cited 1×
“(Means, 2000; Hudmon & Schulman, 2002; Gao et al , 2006; Rezazadeh et al , 2006).”
Cited by
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Suetomi, T., Willeford, A., Brand, C. S., Cho, Y., Ross, R. S., Miyamoto, S., & Brown, J. H. (2018) · Circulation · doi:10.1161/circulationaha.118.034621 · Cited by 304
de Boer, R. A., Hulot, J.-S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2029 · Cited by 183
Self-citationCai, B., Kasikara, C., Doran, A. C., Ramakrishnan, R., Birge, R. B., & Tabas, I. (2018) · Science Signaling · doi:10.1126/scisignal.aar3721 · Cited by 175
Physiological and unappreciated roles of CaMKII in the heart
Beckendorf, J., van den Hoogenhof, M. M. G., & Backs, J. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0688-8 · Cited by 173
“cruzi-associated cardiomyopathy [53], which, we know now, is driven by CaMKII [105].”
BackgroundMethodSelf-citationShumliakivska, M., Luxán, G., Hemmerling, I., Scheller, M., Li, X., Müller-Tidow, C., Schuhmacher, B., Sun, Z., Dendorfer, A., Debes, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43003-w · Cited by 76
Self-citation
Metadata
- Authors
- Weinreuter, M., Kreusser, M. M., Beckendorf, J., Schreiter, F. C., Leuschner, F., Lehmann, L. H., Hofmann, K. P., Rostosky, J. S., Diemert, N., Xu, C., Volz, H. C., Jungmann, A., Nickel, A., Sticht, C., Gretz, N., Maack, C., Schneider, M. D., Gröne, H., Müller, O. J., Katus, H. A., & Backs, J.
- Venue
- EMBO Molecular Medicine
- Published
- 2014-09-05
- Volume
- 6
- Issue
- 10
- Pages
- 1231-1245
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2137238826
- Cited by
- 103
- References
- 6
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.